🟢 GT Biopharma is trading 6.31% up today with no clear company-specific catalyst identified

GT Biopharma is trading at $0.31 (+6.31%) now, though no clear August 24, 2026 company-specific catalyst was identified.

• The latest company release, dated August 14, reported Q2 results, ongoing Phase 1 trials, and approximately $5.1 million in cash runway through Q4 2026.
• SEC records show the latest identified filings were also dated August 14, including the shareholder vote results and 10-Q.
• Broader markets were mixed, so global sentiment does not clearly explain the gain.